Skip to main content
Sign in Create a free account
Varsity Tutors
Sign in

Contraindications And Precautions - NAPLEX

  1. A 34-year-old woman (68 kg, 165 cm) who is 10 weeks pregnant presents with dysuria and urinary frequency. Urinalysis is consistent with uncomplicated cystitis; she is afebrile. Medical history: no chronic conditions. Current medications: prenatal vitamin daily. Allergies: none. Labs: serum creatinine 0.7 mg/dL, AST/ALT within normal limits. Which medication is contraindicated for this patient?
    Answer: Trimethoprim/sulfamethoxazole 160/800 mg by mouth twice daily for 3 days This question tests knowledge of antibiotic safety during pregnancy, specifically first-trimester contraindications. The patient is 10 weeks pregnant with uncomplicated cystitis requiring antibiotic therapy. Trimethoprim/sulfamethoxazole (choice D) is contraindicated in the first trimester due to trimethoprim's antifolate activity, which increases the risk of neural tube defects and other congenital anomalies. Nitrofurantoin (choice A) is safe after the first trimester but should be used with caution in early pregnancy. Cephalexin (choice B) is a pregnancy category B antibiotic and represents the safest choice for this patient. Fosfomycin (choice C) has limited pregnancy data but is generally considered safe. The clinical pearl is that folate antagonists like trimethoprim should be avoided in the first trimester, and beta-lactam antibiotics like cephalexin are preferred for UTI treatment during pregnancy.
  2. A 41-year-old female (62 kg, 170 cm) with bipolar disorder is prescribed a new medication for a urinary tract infection. Current medications: lithium carbonate 900 mg/day (300 mg three times daily), levothyroxine 75 mcg daily. Medical history: bipolar disorder, hypothyroidism. Allergies: none. Labs: lithium level 0.9 mEq/L (therapeutic), SCr 1.0 mg/dL. Which medication is contraindicated for this patient due to a serious drug interaction risk?
    Answer: TMP-SMX 160/800 mg orally twice daily for 3 days This question tests drug interactions between antibiotics and mood stabilizers in urinary tract infection treatment. The key patient-specific factor is the patient's lithium therapy for bipolar disorder, which can lead to toxicity with certain drugs. Trimethoprim-sulfamethoxazole is contraindicated due to its potential to decrease lithium clearance, increasing toxicity risk per interaction data. Nitrofurantoin, ciprofloxacin, and fosfomycin lack significant lithium interactions. These options are suboptimal only if resistance is present but not contraindicated. A pearl is to check for interactions with narrow therapeutic index drugs like lithium, following psychiatric guidelines. Decision-making should prioritize avoiding combinations that alter renal handling of lithium.
  3. A 45-year-old woman (70 kg, 168 cm) with migraine requests an abortive medication. Medical history: uncontrolled hypertension and coronary artery disease with prior myocardial infarction. Current medications: metoprolol succinate 100 mg daily, lisinopril 40 mg daily, aspirin 81 mg daily, rosuvastatin 20 mg nightly. Allergies: none. Vitals today: blood pressure 168/96 mmHg. Labs: serum creatinine 0.8 mg/dL, AST/ALT within normal limits. Which medication is contraindicated for this patient?
    Answer: Sumatriptan 50 mg by mouth once as needed for migraine; may repeat in 2 hours (maximum 200 mg/day) This question evaluates contraindications to triptan therapy in cardiovascular disease. The patient has multiple cardiovascular risk factors including uncontrolled hypertension (168/96 mmHg), coronary artery disease, and prior myocardial infarction. Sumatriptan (choice B) is contraindicated due to its vasoconstrictive properties through 5-HT1B/1D receptor agonism, which can precipitate coronary vasospasm, myocardial ischemia, or stroke in patients with cardiovascular disease. Ubrogepant (choice A), a CGRP receptor antagonist, lacks vasoconstrictive properties and is safe in cardiovascular disease. Acetaminophen (choice C) and metoclopramide (choice D) have no cardiovascular contraindications. The clinical principle is that all triptans are absolutely contraindicated in patients with coronary artery disease, uncontrolled hypertension, or history of stroke, making newer CGRP antagonists valuable alternatives for these patients.
  4. A 66-year-old male (70 kg, 170 cm) is prescribed allopurinol for gout prophylaxis. Current medications: azathioprine 100 mg daily, prednisone 5 mg daily, lisinopril 10 mg daily. Medical history: kidney transplant, gout. Allergies: none. Labs: SCr 1.4 mg/dL, white blood cell count 4.2 x103^3/mcL. Which medication is contraindicated or requires urgent prescriber contact due to a major interaction?
    Answer: Allopurinol 300 mg orally daily This question tests major drug interactions in gout prophylaxis for transplant patients. The key patient-specific factor is the patient's azathioprine use post-kidney transplant, which can lead to bone marrow toxicity with certain drugs. Allopurinol is contraindicated or requires urgent adjustment because it inhibits xanthine oxidase, markedly increasing azathioprine levels and myelosuppression risk. Colchicine, acetaminophen, and febuxostat have fewer interactions, with febuxostat as an alternative. The distractors are safer without dose reductions. A pearl is to reduce azathioprine by 75% if combining with allopurinol, per rheumatology guidelines. Emphasize interaction checking in immunosuppressed patients to prevent toxicity.
  5. A 70-year-old woman (55 kg, 158 cm) presents with worsening knee pain from osteoarthritis. Medical history: heart failure with reduced ejection fraction, chronic kidney disease stage 3a. Current medications: furosemide 40 mg daily, losartan 100 mg daily, spironolactone 25 mg daily, carvedilol 12.5 mg twice daily. Allergies: none. Labs: serum creatinine 1.4 mg/dL (eGFR ~45 mL/min/1.73 m2^2), potassium 5.1 mEq/L (high; normal 3.5–5.0), AST/ALT within normal limits. Which medication is contraindicated for this patient?
    Answer: Ibuprofen 600 mg by mouth three times daily with food This question evaluates NSAID contraindications in patients with cardiovascular and renal disease. The patient has heart failure with reduced ejection fraction, CKD stage 3a, and is on multiple medications that affect renal function and potassium levels, with a current potassium of 5.1 mEq/L (upper limit of normal). Ibuprofen (choice C) is contraindicated due to multiple factors: NSAIDs worsen heart failure by promoting sodium and water retention, reduce renal function in CKD patients, and can cause hyperkalemia, especially when combined with ACE inhibitors/ARBs and potassium-sparing diuretics like spironolactone. Topical diclofenac (choice A) has minimal systemic absorption and is safer. Acetaminophen (choice B) lacks these cardiovascular and renal effects. Intra-articular corticosteroids (choice D) provide local relief without systemic NSAID exposure. The key principle is that oral NSAIDs are contraindicated in heart failure and should be avoided in CKD patients on RAAS inhibitors due to cumulative risks.
  6. A 62-year-old female (72 kg, 158 cm) with chronic kidney disease is prescribed an antibiotic for pyelonephritis. Current medications: none relevant. Medical history: CKD stage 4. Allergies: none. Labs: SCr 2.6 mg/dL (high), CrCl 22 mL/min, potassium 4.2 mEq/L. What adjustment is needed for safe medication use in this patient if levofloxacin is selected?
    Answer: Levofloxacin 750 mg orally once, then 750 mg orally every 48 hours (renal adjustment) This question assesses renal dose adjustments for antibiotics in pyelonephritis treatment. The key patient-specific factor is the patient's CKD stage 4 with CrCl 22 mL/min, necessitating dose reduction to prevent toxicity. Administering levofloxacin 750 mg once, then every 48 hours is the best adjustment per manufacturer guidelines for CrCl 20-49 mL/min to maintain efficacy while reducing accumulation. No adjustment risks overdose; complete contraindication is inaccurate as adjusted use is allowed; lower daily dose without loading may underexpose initially. The distractors could lead to subtherapeutic or toxic levels. A pearl is to use Cockcroft-Gault for antibiotic dosing, following IDSA guidelines. Emphasize renal function-based adjustments to optimize outcomes and safety.
  7. A 50-year-old male (95 kg, 178 cm) with uncontrolled hypertension is prescribed a new medication. Current medications: lisinopril 40 mg daily, amlodipine 10 mg daily. Medical history: hypertension, history of angioedema with lisinopril requiring emergency care 2 years ago. Allergies: none listed beyond prior angioedema reaction. Labs: SCr 1.0 mg/dL, potassium 4.4 mEq/L. Which medication is contraindicated for this patient?
    Answer: Lisinopril 20 mg orally daily (restart) This question examines contraindications for antihypertensives based on adverse reaction history. The key patient-specific factor is the patient's history of angioedema with lisinopril, indicating a class effect risk. Lisinopril is contraindicated because restarting an ACE inhibitor after angioedema can precipitate recurrent, potentially life-threatening episodes. Hydrochlorothiazide, losartan, and spironolactone lack this risk. The distractors are safe alternatives. A pearl is to document angioedema as an allergy to all ACE inhibitors, per hypertension guidelines. Decision-making should avoid re-challenge to prevent airway compromise.
  8. A 56-year-old male (86 kg, 177 cm) with chronic pain is prescribed tramadol. Current medications: phenelzine 15 mg orally three times daily, amlodipine 5 mg daily. Medical history: depression treated with a monoamine oxidase inhibitor (MAOI). Allergies: none. Labs: SCr 0.9 mg/dL, AST/ALT normal. Which medication is contraindicated for this patient?
    Answer: Tramadol 50 mg orally every 6 hours as needed This question tests contraindications for analgesics in patients on monoamine oxidase inhibitors. The key patient-specific factor is the patient's phenelzine (MAOI) therapy, increasing serotonin syndrome risk. Tramadol is contraindicated because its serotonergic effects combined with MAOIs can precipitate serotonin syndrome, including agitation and hyperthermia. Acetaminophen, topical diclofenac, and naproxen lack serotonergic activity. The distractors are safer for pain management. A pearl is to avoid serotonergic agents within 14 days of MAOIs, per psychiatric guidelines. Decision frameworks should include interaction screening to prevent neurologic crises.
  9. A 39-year-old male (92 kg, 182 cm) is prescribed sildenafil for erectile dysfunction. Current medications: nitroglycerin 0.4 mg sublingual as needed for chest pain, metoprolol tartrate 50 mg twice daily, rosuvastatin 20 mg nightly. Medical history: stable angina, hypertension, hyperlipidemia. Allergies: none. Labs: SCr 1.0 mg/dL, AST/ALT normal. Which medication is contraindicated for this patient due to current therapy?
    Answer: Sildenafil 50 mg orally as needed (maximum once daily) This question evaluates contraindications for PDE5 inhibitors in patients using nitrates. The key patient-specific factor is the patient's nitroglycerin use for stable angina, which can cause severe hypotension when combined with certain drugs. Sildenafil is contraindicated because PDE5 inhibitors potentiate nitrate-induced vasodilation, leading to life-threatening hypotension. Tadalafil has similar risks but is not the selected choice; nitroglycerin is current therapy; acetaminophen is unrelated. The distractors do not share the interaction severity. A clinical pearl is to counsel on nitrate-PDE5 spacing, per ACC guidelines. Decision-making should prioritize avoiding hypotensive synergies in cardiovascular patients.
  10. A 46-year-old male (105 kg, 180 cm) with type 2 diabetes requests a refill for metformin. Current medications: metformin 1,000 mg orally twice daily, losartan 50 mg daily. Medical history: type 2 diabetes, chronic kidney disease. Allergies: none. Labs today: SCr 2.3 mg/dL (high), estimated glomerular filtration rate (eGFR) 25 mL/min/1.73 m2^2 (low; normal >60), A1c 7.8%. What adjustment is needed for safe medication use in this patient?
    Answer: Discontinue metformin due to eGFR 25 mL/min/1.73 m2^2 This question assesses precautions and contraindications for metformin in diabetic patients with renal dysfunction. The key patient-specific factor is the patient's eGFR of 25 mL/min/1.73 m², which heightens lactic acidosis risk. Discontinuing metformin is the best choice because it is contraindicated when eGFR falls below 30 mL/min/1.73 m² per FDA labeling. Continuing without change or increasing the dose ignores renal risks; switching to extended-release does not mitigate the contraindication at this eGFR. These options are incorrect as they could lead to toxicity. A clinical pearl is to monitor eGFR regularly in metformin users, following ADA guidelines for dose adjustments. Decision frameworks should include renal function assessment to prevent rare but serious adverse events like lactic acidosis.
  11. A 74-year-old male (68 kg, 173 cm) presents with acute low back muscle spasm and requests a muscle relaxant. Current medications: donepezil 10 mg nightly, memantine 10 mg twice daily, tamsulosin 0.4 mg nightly. Medical history: Alzheimer disease, falls in the past year. Allergies: none. Labs: SCr 1.0 mg/dL, AST/ALT normal. Which medication should be avoided due to age-related precaution (fall risk and anticholinergic burden)?
    Answer: Cyclobenzaprine 10 mg orally three times daily as needed This question evaluates age-related precautions for muscle relaxants in elderly patients. The key patient-specific factor is the patient's age of 74 years with Alzheimer disease and fall history, increasing anticholinergic and sedation risks. Cyclobenzaprine should be avoided because it has high anticholinergic burden, exacerbating fall risk and cognitive impairment in the elderly. Acetaminophen is safe for pain; topical lidocaine has minimal systemic effects; physical therapy is non-pharmacologic. The distractors lack similar risks. A pearl is to use Beers Criteria to avoid high-risk medications in older adults. Emphasize minimizing anticholinergics to prevent falls and delirium.
  12. A 34-year-old female (70 kg, 165 cm) presents to urgent care with dysuria and urinary frequency; the prescriber plans empiric treatment for uncomplicated cystitis. Current medications: ethinyl estradiol/levonorgestrel 1 tablet daily, sertraline 50 mg daily. Medical history: glucose-6-phosphate dehydrogenase (G6PD) deficiency, depression. Allergies: none. Labs: serum creatinine (SCr) 0.8 mg/dL, alanine aminotransferase (ALT) 18 units/L. Which medication is contraindicated for this patient?
    Answer: Nitrofurantoin 100 mg orally twice daily for 5 days This question tests knowledge of contraindications for antibiotics in treating uncomplicated cystitis, emphasizing patient-specific risk factors like enzyme deficiencies. The key patient-specific factor is the patient's glucose-6-phosphate dehydrogenase (G6PD) deficiency, which increases the risk of hemolytic anemia with certain medications. Nitrofurantoin is contraindicated in this patient because it can induce hemolytic anemia in individuals with G6PD deficiency due to oxidative stress on red blood cells. Fosfomycin is not contraindicated and is a recommended first-line option for uncomplicated cystitis; trimethoprim-sulfamethoxazole carries a risk but is not as directly linked to hemolysis in all guidelines; cephalexin is safe as a beta-lactam alternative without G6PD-related risks. A transferable clinical pearl is to always screen for G6PD deficiency before prescribing oxidants like nitrofurantoin or sulfonamides, following IDSA guidelines for UTI management. Guideline-based decision-making involves selecting antibiotics with the lowest risk profile based on patient comorbidities to prevent adverse events like hemolysis.
  13. A 27-year-old female (64 kg, 167 cm) who is breastfeeding a 2-week-old infant presents with insomnia and asks for a sleep aid. Current medications: prenatal vitamin, ibuprofen 400 mg as needed. Medical history: none. Allergies: none. Labs: not available/needed. Which medication should be avoided due to breastfeeding safety concerns?
    Answer: Diphenhydramine 50 mg orally at bedtime as needed This question examines safety concerns for sleep aids during breastfeeding. The key patient-specific factor is the patient's breastfeeding status with a 2-week-old infant, risking infant exposure via milk. Diphenhydramine should be avoided because it can cause sedation in the breastfed infant and potentially decrease milk supply due to anticholinergic effects. Sleep hygiene is preferred non-pharmacologic; melatonin has limited data but lower risks; doxylamine is similar but at lower dose. The distractors are less concerning for infant safety. A pearl is to recommend behavioral interventions first in lactating women, per AAP guidelines. Decision frameworks should weigh infant exposure risks in medication selection.
  14. A 48-year-old male (110 kg, 183 cm) with hypertriglyceridemia is prescribed a statin. Current medications: gemfibrozil 600 mg orally twice daily, metformin 500 mg twice daily. Medical history: type 2 diabetes, hypertriglyceridemia. Allergies: none. Labs: AST 28 units/L, ALT 30 units/L, SCr 1.0 mg/dL. Which medication is contraindicated or should be avoided due to high risk of myopathy/rhabdomyolysis with the current regimen?
    Answer: Simvastatin 40 mg orally nightly This question assesses drug interactions for statins in hypertriglyceridemia management. The key patient-specific factor is the patient's gemfibrozil therapy, which increases myopathy risk via CYP inhibition. Simvastatin is contraindicated because gemfibrozil significantly elevates its levels, heightening rhabdomyolysis risk per FDA labeling. Atorvastatin, pravastatin, and rosuvastatin have lower interaction severity with dose limits. The distractors are usable with monitoring. A pearl is to limit simvastatin to 10 mg if unavoidable, but avoidance is preferred per lipid guidelines. Decision-making should prioritize low-interaction statins to prevent muscle toxicity.
  15. A 58-year-old man (92 kg, 178 cm) presents to urgent care for acute low back pain after lifting a heavy box. Medical history includes asthma with nasal polyps and a documented aspirin-exacerbated respiratory disease; no kidney or liver disease. Current medications: budesonide/formoterol 160/4.5 mcg 2 inhalations twice daily, albuterol HFA 2 inhalations every 4–6 hours as needed, montelukast 10 mg nightly. Allergies: aspirin (bronchospasm), ibuprofen (wheezing). Labs: serum creatinine 0.9 mg/dL, AST/ALT within normal limits. Which medication should be avoided in this patient due to their allergy?
    Answer: Naproxen 500 mg by mouth twice daily with food This question tests the recognition of cross-reactivity between NSAIDs in patients with aspirin-exacerbated respiratory disease (AERD). The patient has documented AERD with aspirin-induced bronchospasm and ibuprofen-induced wheezing, indicating sensitivity to COX-1 inhibiting NSAIDs. Naproxen (choice B) is contraindicated because it shares the same COX-1 inhibition mechanism as aspirin and ibuprofen, carrying a high risk of triggering bronchospasm in this patient. Acetaminophen (choice A) is the safest analgesic option as it has minimal COX inhibition and is well-tolerated in AERD patients. Cyclobenzaprine (choice C) is a muscle relaxant without NSAID properties, and lidocaine patches (choice D) provide local analgesia without systemic NSAID exposure. The clinical pearl is that patients with AERD should avoid all non-selective NSAIDs, and acetaminophen remains the first-line oral analgesic for these patients.
  16. A 72-year-old woman (60 kg, 160 cm) is being treated for an acute gout flare. Medical history: chronic kidney disease stage 4, hypertension, and osteoarthritis. Current medications: lisinopril 20 mg daily, amlodipine 5 mg daily, acetaminophen 500 mg every 8 hours as needed. Labs: serum creatinine 2.6 mg/dL (eGFR ~18 mL/min/1.73 m2^2), AST/ALT within normal limits. The prescriber orders colchicine 1.2 mg now, then 0.6 mg 1 hour later, then 0.6 mg twice daily for 7 days. What adjustment is needed for safe medication use in this patient?
    Answer: Reduce colchicine to a single 0.6 mg dose; do not repeat the course for at least 2 weeks in severe renal impairment This question evaluates the appropriate dosing adjustment of colchicine in severe renal impairment. The patient has an eGFR of 18 mL/min/1.73 m², indicating severe renal impairment (CKD stage 4), which significantly reduces colchicine clearance and increases toxicity risk. The correct adjustment (choice C) is to reduce colchicine to a single 0.6 mg dose without repeating for at least 2 weeks, as recommended by FDA guidelines for severe renal impairment. Choice A is incorrect because normal hepatic function doesn't negate the need for renal adjustment. Choice B incorrectly suggests using allopurinol for acute flares, when it's only for chronic management. Choice D dangerously suggests increasing the dose when reduction is needed. The key principle is that colchicine requires significant dose reduction in severe renal impairment due to decreased clearance and increased risk of life-threatening toxicity.
  17. A 29-year-old man (78 kg, 182 cm) with epilepsy presents to the pharmacy with a new prescription for an antibiotic for sinusitis. Medical history: focal seizures controlled on lamotrigine. Current medications: lamotrigine 200 mg by mouth twice daily. Allergies: none. Labs: serum creatinine 0.9 mg/dL, AST/ALT within normal limits. The new prescription is for trimethoprim/sulfamethoxazole 160/800 mg by mouth twice daily for 10 days. What precaution should be taken when prescribing this medication?
    Answer: Avoid coadministration or use an alternative antibiotic due to increased risk of serious rash with lamotrigine This question addresses the serious drug interaction between lamotrigine and trimethoprim/sulfamethoxazole. The patient is on lamotrigine for seizure control and requires antibiotic therapy for sinusitis. The critical safety concern (choice A) is that trimethoprim/sulfamethoxazole significantly increases the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis when combined with lamotrigine, particularly during the first 8 weeks of therapy but also with established lamotrigine use. Choice B incorrectly suggests increasing lamotrigine, when the concern is toxicity, not reduced efficacy. Choices C and D describe interactions not relevant to this drug combination. The clinical pearl is that lamotrigine carries a black box warning for serious rash, and concurrent use of drugs that inhibit lamotrigine metabolism (like trimethoprim) substantially increases this risk, making alternative antibiotics preferable for patients on lamotrigine therapy.
  18. A 29-year-old female (60 kg, 168 cm) at 10 weeks gestation presents with severe acne flare and asks about restarting a prior medication. Current medications: prenatal vitamin 1 tablet daily, doxylamine/pyridoxine 10 mg/10 mg at bedtime. Medical history: acne vulgaris. Allergies: none. Labs: SCr 0.6 mg/dL, AST 16 units/L, ALT 14 units/L. Which medication is contraindicated for this patient?
    Answer: Isotretinoin 40 mg orally daily This question evaluates contraindications for acne treatments during pregnancy, highlighting teratogenic risks. The key patient-specific factor is the patient's pregnancy at 10 weeks gestation, which necessitates avoiding category X medications. Isotretinoin is contraindicated because it is highly teratogenic, causing severe birth defects like craniofacial and cardiac abnormalities. Azelaic acid is safe (category B) for topical use; benzoyl peroxide is acceptable with low systemic absorption; clindamycin topical is generally safe without pregnancy-related risks. The distractors are incorrect as they do not carry the same level of fetal harm. A transferable pearl is to always confirm pregnancy status before prescribing retinoids, adhering to iPLEDGE program requirements. Guideline-based decisions from the American Academy of Dermatology emphasize risk-benefit assessment in pregnant patients to prevent avoidable teratogenicity.
  19. A 59-year-old female (80 kg, 165 cm) with type 2 diabetes and a history of medullary thyroid carcinoma in a first-degree relative asks about starting a GLP-1 receptor agonist for weight loss and glycemic control. Current medications: metformin 1,000 mg twice daily, atorvastatin 20 mg nightly. Medical history: type 2 diabetes, obesity; family history: medullary thyroid carcinoma. Allergies: none. Labs: A1c 8.2%, SCr 0.9 mg/dL. Which medication is contraindicated or should be avoided given this history?
    Answer: Semaglutide 0.25 mg subcutaneously once weekly (titration planned) This question assesses contraindications for antidiabetic agents based on family history. The key patient-specific factor is the family history of medullary thyroid carcinoma, raising concerns for C-cell tumors. Semaglutide is contraindicated or should be avoided because GLP-1 agonists carry a boxed warning for thyroid C-cell tumors in patients with personal or family history of MTC or MEN2. Empagliflozin, sitagliptin, and pioglitazone lack this risk. The distractors are appropriate for glycemic control. A pearl is to screen for MTC history before GLP-1 initiation, following ADA guidelines. Decision-making should include genetic risk assessment to avoid promoting rare malignancies.
  20. A 60-year-old female (74 kg, 162 cm) presents with acute bacterial sinusitis and is prescribed an antibiotic. Current medications: dofetilide 500 mcg orally twice daily, hydrochlorothiazide 25 mg daily. Medical history: atrial fibrillation (on dofetilide). Allergies: penicillin (rash). Labs: SCr 0.9 mg/dL, potassium 3.6 mEq/L. Which medication is contraindicated for this patient?
    Answer: Trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for 7 days This question tests contraindications for antibiotics in patients on QT-prolonging antiarrhythmics. The key patient-specific factor is the patient's dofetilide therapy for atrial fibrillation, which increases torsades de pointes risk. Trimethoprim-sulfamethoxazole is contraindicated because it can prolong the QT interval, potentiating arrhythmias with dofetilide. Doxycycline, amoxicillin-clavulanate, and cefpodoxime do not significantly affect QT. These options are acceptable alternatives post-allergy consideration. A pearl is to review QT risks before prescribing in arrhythmia patients, following AHA guidelines. Emphasize avoiding additive QT-prolonging agents to mitigate cardiac events.

Start this quiz